Empirical Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $914K | Buy |
2,052
+215
| +12% | +$95.7K | 0.02% | 320 |
|
|
2025
Q1 | $891K | Buy |
1,837
+1,146
| +166% | +$556K | 0.02% | 310 |
|
|
2024
Q4 | $278K | Sell |
691
-153
| -18% | -$61.6K | 0.01% | 515 |
|
|
2024
Q3 | $393K | Sell |
844
-3
| -0.4% | -$1.4K | 0.01% | 413 |
|
|
2024
Q2 | $397K | Sell |
847
-404
| -32% | -$189K | 0.01% | 398 |
|
|
2024
Q1 | $523K | Buy |
1,251
+203
| +19% | +$84.9K | 0.02% | 333 |
|
|
2023
Q4 | $426K | Buy |
1,048
+68
| +7% | +$27.7K | 0.01% | 343 |
|
|
2023
Q3 | $341K | Sell |
980
-21
| -2% | -$7.3K | 0.01% | 350 |
|
|
2023
Q2 | $352K | Sell |
1,001
-345
| -26% | -$121K | 0.01% | 351 |
|
|
2023
Q1 | $424K | Hold |
1,346
| – | – | 0.02% | 348 |
|
|
2022
Q4 | $389K | Sell |
1,346
-39
| -3% | -$11.3K | 0.02% | 348 |
|
|
2022
Q3 | $401K | Sell |
1,385
-393
| -22% | -$114K | 0.02% | 331 |
|
|
2022
Q2 | $501K | Sell |
1,778
-307
| -15% | -$86.5K | 0.03% | 294 |
|
|
2022
Q1 | $544K | Sell |
2,085
-1,815
| -47% | -$474K | 0.03% | 316 |
|
|
2021
Q4 | $856K | Sell |
3,900
-2,072
| -35% | -$455K | 0.04% | 243 |
|
|
2021
Q3 | $1.08M | Buy |
5,972
+2,031
| +52% | +$368K | 0.06% | 180 |
|
|
2021
Q2 | $795K | Buy |
3,941
+1,529
| +63% | +$308K | 0.05% | 219 |
|
|
2021
Q1 | $518K | Buy |
+2,412
| New | +$518K | 0.04% | 242 |
|